Tumor-infiltrating Batf3 DCs take up tumor-associated antigens and migrate through lymphatic vessels to tumor-draining lymph nodes, where antigens are captured on major histocompatibility complex (MHC) I and MHC II molecules are presented to T cells and tumor-specific CD8+ T cells are cross-activated. Here, BATF3 is linked to neoplasm.